principal concerns are:

1. **The audit does not establish whether the expert labels are recoverable from the displayed slices.**

   Section 3.1 reports 38% agreement between a simplified automated rule and expert RANO ratings. However, disagreement can arise because the rule implements a different target. The limitations acknowledge that “complete response” can include residual subthreshold disease and that the rule omits the new-lesion criterion. Appendix D finds another newly measurable component in 22 of the 46 rule-CR/expert-PD disagreements.

   The paper appropriately acknowledges these issues, but the introduction still presents an audit through which “answerability is checked rather than assumed.” That is stronger than the evidence supports. **Rule–expert agreement is checked; slice answerability remains unvalidated.**

   A focused clinician review of the actual displayed inputs would materially strengthen this contribution. Without it, frame the audit strictly as disagreement between two labeling procedures.
2. **The donor permutation needs a more explicit statistical justification.**

   The main methodological interpretation depends heavily on the donor-label permutation. Appendix D acknowledges that it does not preserve image-count strata or donor reuse and does not reconstruct the assignment mechanism.

   The 2,000 null simulations and comparison with a repair-free sampler are reassuring. They do not, by themselves, establish validity for every relevant no-tracking mechanism. In particular, agreement between two samplers does not establish that either samples the intended null distribution.

   State the null hypothesis, conditioning variables, and exchangeability assumptions explicitly. Either preserve the relevant assignment constraints or justify why discarding them is valid for the narrower association test. Replace the general claim that the repair “controls the test’s false-positive rate” with a claim restricted to the simulated settings.
3. **The worked example sometimes treats insufficient evidence as a stronger diagnosis of what happened.**

   Llama-4-Scout improves from 8.7% to 54.3% on DSCR. Falling below the 58.7% majority baseline does not exclude useful image information: a model can read some images correctly while performing poorly overall.

   Similarly, a donor permutation result of p=.244 does not establish that the improvement comes from a generic image-presence effect. Figure 3’s statement that “the drop is the no-image arm collapsing” suggests an explanation that has not been isolated.

   The defensible conclusion is:

   > The image improves accuracy, but these experiments do not establish whether the improvement reflects donor-specific category recognition.

   Much of the prose already follows this interpretation. Make the figure, abstract, and conclusion equally consistent.
4. **The positive-control gate is sensitive to the inference procedure.**

   Llama-4-Scout passes the AIA gate using its bootstrap interval, while its exact McNemar test gives p=.070. Under the exact test, no open model passes. Table 3 also contains other instances where bootstrap intervals exclude zero despite nonsignificant exact tests.

   Reporting these discrepancies is good practice. Nevertheless, the gate determines how downstream results are interpreted, so its sensitivity matters. Preserve the prespecified analysis, but present the alternative gate interpretation clearly and avoid making substantive conclusions depend on this borderline pass. Sequence recognition also measures a different capability from lesion localization; it is a useful diagnostic control, not a universal prerequisite for visual competence.
5. **The novelty needs sharper positioning against existing counterfactual evaluation.**

   HEAL-MedVQA already replaces a relevant region with one from a different class and evaluates the expected answer change. Thus, its protocol is more directed than measuring arbitrary response changes. [Nguyen et al., 2025](<https://www.ijcai.org/proceedings/2025/0853.pdf>)

   Your distinctive contribution appears to be the combination of multiclass donor-key scoring, subtraction of the text-only baseline, and a conditional association test. Table 5 is particularly valuable: the generic image shift and noisy tracker both achieve +19 points of donor gain, but the permutation distinguishes them. Move this result into the main paper and explain precisely what the combined procedure adds. A new full benchmark comparison is not necessarily required.

**The five-phase structure also weakens the paper’s focus.** PJRF has unverified outcome timing and contributes no substantive conclusion. TCM evaluates a simplified rule that is absent from the primary prompts, complicating its interpretation as rule adherence. I would center the paper on AIA/LIL/DSCR and treat the chain experiments as a secondary extension.

Presentation is generally readable, although Table 3 is dense. More importantly, Figure 3 calls the additions “prespecified” while relying on a post hoc permutation; its caption acknowledges this, but the visual should make the distinction directly.

**What would change my recommendation:** resolve the donor-test assumptions, narrow the audit and worked-example claims, and provide targeted validation of the DSCR items. I would not require a larger model leaderboard merely for completeness. These revisions address the evidence supporting the central contribution, consistent with [ARR’s emphasis on appropriately scoped, supported claims](<https://aclrollingreview.org/reviewerguidelines>).
